Lamotrigine Teva (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which stabilizes the neuronal membrane and reduces the release of excitatory neurotransmitters such as glutamate. This action diminishes the rapid firing of neurons that underlies seizures and contributes to mood stabilization in bipolar disorder.

The specific dose of Lamotrigine Teva is individualized by the prescribing clinician based on the patient’s age, indication, renal function, and any concomitant medications. Dosage adjustments are made during titration to achieve therapeutic effect while minimizing adverse reactions.

Safety data for lamotrigine in pregnancy and lactation are limited. Clinicians should evaluate the potential benefits against possible risks to the fetus or infant. If treatment is continued, close monitoring is recommended, and breastfeeding decisions should be made in consultation with a healthcare professional.

To order Lamotrigine Teva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with alternatives such as carbamazepine or valproate, lamotrigine generally has a lower risk of weight gain and sedation but requires careful titration to avoid skin reactions. It is often preferred for patients needing mood stabilization, whereas carbamazepine may be more effective for certain focal seizures, and valproate is broad‑spectrum but carries higher teratogenic risk.

Lamotrigine Teva should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in areas with high humidity or direct sunlight.

Lamotrigine Teva is taken orally, usually as a tablet, with or without food as directed by the prescriber. The medication is typically started at a low dose and increased gradually according to a titration schedule to minimize the risk of rash and other adverse effects.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like agranulocytosis, hepatic failure, and the emergence of suicidal thoughts or behavior. Patients should seek immediate medical attention if they develop a widespread rash, fever, or any signs of severe hypersensitivity.

Lamotrigine Teva is contraindicated in individuals with a known hypersensitivity to lamotrigine or any of its excipients. Patients with a history of severe skin reactions to antiepileptic drugs should avoid it, and those with uncontrolled hepatic or severe renal impairment should be evaluated carefully before use.